The U.S. Food and Drug Administration had data 15 years ago showing over-the-counter sleep aid products such as Tylenol PM and Excedrin PM don’t offer a significant benefit to patients, according to a letter obtained by CBC News.
The U.S. Food and Drug Administration had data 15 years ago showing over-the-counter sleep aid products such as Tylenol PM and Excedrin PM don’t offer a significant benefit to patients, according to a letter obtained by CBC News.
Health regulators recently reported that Tylenol PM, and other acetaminophen pain drugs that include a sleep-aid, failed to show any significant benefit.
Tylenol PM and other widely used acetaminophen pain drugs that include a sleep-aid failed to show significant benefit in a key study, U.S. health regulators have told drugmakers 15 years after the industry submitted the data.
Tylenol PM and other widely used acetaminophen pain drugs that include a sleep-aid failed to show any significant benefit in a key study, U.S. health regulators have told drugmakers 15 years after industry submitted the data.
